Sign up to save your podcasts
Or
Share A One-Time Shot for Type 2 Diabetes? A Biotech Company Is On It
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A One-Time Shot for Type 2 Diabetes? A Biotech Company Is On It
Fractyl Health is developing a gene therapy alternative to drugs like Ozempic and Wegovy to control blood sugar and body weight without repeated injections. Thanks for listening to WIRED. Talk to you next time for more stories from WIRED.com and read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices
View all episodes
By WIRED
3.7
102102 ratings
Fractyl Health is developing a gene therapy alternative to drugs like Ozempic and Wegovy to control blood sugar and body weight without repeated injections. Thanks for listening to WIRED. Talk to you next time for more stories from WIRED.com and read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices
More shows like What's New
View all
Freakonomics Radio
32,005 Listeners
Planet Money
30,681 Listeners
Marketplace
8,764 Listeners
Economist Podcasts
4,162 Listeners
Marketplace Tech
1,276 Listeners
WSJ Your Money Briefing
1,705 Listeners
WSJ What’s News
4,339 Listeners
Bloomberg Businessweek
423 Listeners
WSJ Tech News Briefing
1,639 Listeners
Uncanny Valley | WIRED
500 Listeners
Science, Spoken
56 Listeners
Business, Spoken
49 Listeners
WSJ Minute Briefing
676 Listeners
Security, Spoken
60 Listeners
Bold Names
1,446 Listeners
TechCrunch Daily Crunch
42 Listeners
Citadel Dropouts: a Game of Thrones Podcast
77 Listeners
The Journal.
6,092 Listeners
Bloomberg Tech
62 Listeners